Substitution management in opioid dependence

Area of Science:

• Addiction Medicine
• Pharmacology
• Public Health Policy

Background:

• Substitution treatment is the primary therapeutic strategy for heroin dependence.
• Methadone maintenance is the established standard, with buprenorphine and combined therapies gaining prominence.
• Opioid dependence requires comprehensive management within a therapeutic network.

Purpose of the Study:

• To review key research findings on substitution treatments for heroin dependence.
• To outline consequences for best practice guidelines in addiction treatment.
• To describe the evolution and organization of substitution treatment in Europe.

Main Methods:

• Literature review of substitution treatment research.
• Analysis of European substitution treatment regulations and organization.
• Identification of emerging trends and future directions.

Main Results:

• Methadone maintenance remains the gold standard, but buprenorphine and combined agonist-antagonist compounds are increasingly utilized.
• Significant discrepancies exist in administrative regulations governing substitution treatment across Europe.
• Emerging trends indicate a move towards more flexible and integrated treatment approaches.

Conclusions:

• Substitution treatment is a cornerstone of opioid dependence management, with ongoing evolution in therapeutic options.
• Harmonization of administrative regulations is needed to optimize substitution treatment delivery in Europe.
• Further research and policy development are essential to enhance the comprehensive care network for opioid dependence.